Bloniecki, V., Aarsland, D., Blennow, K., Cummings, J., Falahati, F., Winblad, B., & Freund-Levi, Y. (2017). Effects of Risperidone and Galantamine treatment on Alzheimer biomarker levels in cerebrospinal fluid. J Alzheimers Dis.
Citação norma ChicagoBloniecki, Victor, Dag Aarsland, Kaj Blennow, Jeffrey Cummings, Farshad Falahati, Bengt Winblad, and Yvonne Freund-Levi. "Effects of Risperidone and Galantamine Treatment On Alzheimer Biomarker Levels in Cerebrospinal Fluid." J Alzheimers Dis 2017.
Citação norma MLABloniecki, Victor, et al. "Effects of Risperidone and Galantamine Treatment On Alzheimer Biomarker Levels in Cerebrospinal Fluid." J Alzheimers Dis 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.